California State Teachers Retirement System boosted its stake in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 24.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 72,518 shares of the electronics maker’s stock after acquiring an additional 14,270 shares during the period. California State Teachers Retirement System’s holdings in Dolby Laboratories were worth $4,355,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Quantinno Capital Management LP raised its holdings in shares of Dolby Laboratories by 23.0% in the 1st quarter. Quantinno Capital Management LP now owns 58,316 shares of the electronics maker’s stock valued at $3,503,000 after purchasing an additional 10,887 shares in the last quarter. Entropy Technologies LP acquired a new position in shares of Dolby Laboratories during the first quarter worth $1,674,000. Hilltop Holdings Inc. purchased a new position in Dolby Laboratories in the first quarter valued at $908,000. Modern Wealth Management LLC purchased a new position in Dolby Laboratories in the first quarter valued at $288,000. Finally, Arrowstreet Capital Limited Partnership raised its stake in Dolby Laboratories by 507.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 124,509 shares of the electronics maker’s stock valued at $7,478,000 after buying an additional 104,014 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Insider Buying and Selling at Dolby Laboratories
In other news, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction on Friday, May 15th. The shares were sold at an average price of $54.90, for a total value of $164,700.00. Following the transaction, the senior vice president directly owned 80,603 shares of the company’s stock, valued at $4,425,104.70. The trade was a 3.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP John D. Couling sold 7,667 shares of the company’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $60.00, for a total transaction of $460,020.00. Following the completion of the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at approximately $7,123,620. This trade represents a 6.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 43,128 shares of company stock valued at $2,405,917. 37.93% of the stock is currently owned by insiders.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on DLB
Dolby Laboratories Stock Performance
Shares of DLB stock opened at $61.70 on Friday. The stock’s 50-day moving average is $52.82 and its two-hundred day moving average is $58.49. Dolby Laboratories has a 1 year low of $48.26 and a 1 year high of $75.66. The firm has a market cap of $5.78 billion, a price-to-earnings ratio of 26.26 and a beta of 0.80.
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The business had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The business’s quarterly revenue was down 3.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, research analysts predict that Dolby Laboratories will post 3.21 EPS for the current year.
Dolby Laboratories announced that its Board of Directors has authorized a stock repurchase program on Thursday, July 30th that allows the company to buyback $350.00 million in shares. This buyback authorization allows the electronics maker to buy up to 7% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.
Dolby Laboratories Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be given a dividend of $0.36 per share. The ex-dividend date is Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. Dolby Laboratories’s dividend payout ratio (DPR) is 61.28%.
Dolby Laboratories Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
